Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06294288
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-05
First Post:
2024-02-20
Brief Title:
A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants
Sponsor:
Longbio Pharma
Organization:
Longbio Pharma
Study Overview
Official Title:
To Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Escalating Single and Multiple Doses of LP-003 in Healthy Volunteers
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate safety tolerability immunogenicity pharmacokinetics pharmacodynamics and efficacy of LP-003 in healthy volunteers The study will be conducted in 2 parts Part 1 the single ascending dose SAD is the first in human FIH study of LP-003 and Part 2 multiple ascending dose MAD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None